Ethics and Public Policy Center

The Ethics and Public Policy Center (EPPC) is a conservative^[2][3] Washington, D.C.–based think tank and advocacy group. Founded in 1976, the group describes itself as "working to apply the riches of the Jewish and Christian traditions to contemporary questions of law, culture, and politics, in pursuit of America's continued civic and cultural renewal."^[4]

Ethics and Public Policy Center

Formation	1976; 49 years ago (1976)
Founder	Ernest W. Lefever
Headquarters	1730 M Street, N.W., Suite 910, Washington, D.C.
President	Ryan T. Anderson
Vice President	Edward Whelan
Revenue	$8,450,000[1] (2024)
Expenses	$7,320,000[1] (2024)
Website	eppc.org

Since February 2021, EPPC's president has been Ryan T. Anderson, who previously worked at the Heritage Foundation, succeeding Edward Whelan,^[5] who serves as EPPC's vice president.^[6] Former president of EPPC from 1989 through June 1996, George Weigel, Catholic theologian and papal biographer, is also a distinguished senior fellow.^[7] EPPC is a 501(c)(3) organization.^[8][9]

History

EPPC was founded in 1976 by Ernest W. Lefever, an American political theorist. He was nominated in 1981 for a United States Department of State position by U.S. President Ronald Reagan before ultimately being rejected for the opportunity for his controversial background.^[10] He served as president of EPPC until 1989 and continued to write scholarly articles for EPPC until his death in 2009.^[11] Lefever said upon founding the institute that "a small ethically oriented center" should "respond directly to ideological critics who insist the corporation is fundamentally unjust."^[12]

From 2003 to 2018, EPPC published The New Atlantis: A Journal of Technology and Society.^[13] In January 2018, The New Atlantis became independent of EPPC and is now published by the Center for the Study of Technology and Society.^[14]

EPPC is a member of the advisory board of Project 2025.^[15][16]

Model legislation and studies

IVF model legislation

In 2025, legislation based on proposals from the Ethics and Public Policy Center (EPPC) was enacted in Arkansas and Utah. In Arkansas, Governor Sarah Huckabee Sanders signed a law on April 22 addressing infertility through alternatives to in vitro fertilization (IVF), reflecting a model developed by EPPC policy analyst Natalie Dodson.^[17] The law followed the publication of an EPPC report outlining ethical treatments for infertility. In Utah, Governor Spencer Cox signed SB 334 into law on March 24. The law, based on model legislation by EPPC senior fellow Stanley Kurtz, requires students at Utah State University to complete a year-and-a-half course in Western civilization and a one-semester course in American civics.^[18][19]

Abortion pill study

In April 2025, researchers Jamie Bryan Hall and Ryan T. Anderson published a large-scale observational study analyzing the safety of mifepristone, a drug commonly used for medication abortion. Using data from a comprehensive all-payer insurance claims database, the study examined 865,727 mifepristone abortions performed in the United States between 2017 and 2023. The study reported that 10.93 percent of women experienced serious adverse events within 45 days of taking mifepristone. These events included sepsis, infection, hemorrhage, surgery, and hospitalization. The reported complication rate was significantly higher than the less than 0.5 percent rate found in earlier clinical trials referenced by the U.S. Food and Drug Administration (FDA). The authors attributed the discrepancy to differences between clinical trial conditions and real-world medical practice. They argued that current FDA safety protocols are insufficient and recommended reinstating earlier safeguards. These included physician-only prescribing, in-person medical supervision, and mandatory reporting of adverse events. The study concluded that the FDA should reassess the approval and regulation of mifepristone based on updated safety data.^[20]

The study’s findings were referenced during a United States Senate hearing on May 14, 2025, when Senator Josh Hawley cited the data in a discussion with Secretary of Health and Human Services Robert Kennedy Jr.^{[21][better source needed]} In response, Secretary Kennedy stated that he had requested Food and Drug Administration Commissioner Martin Makary to conduct a full review of the safety profile of mifepristone. On June 2, 2025, Commissioner Makary confirmed in a letter to Senator Hawley that such a review would be undertaken.^{[22][better source needed]}

Judicial involvement and public comments

On May 1, 2025, Ryan T. Anderson was appointed to President Donald Trump’s Religious Liberty Commission.^[23][24]

EPPC staff submitted public comments supporting the Department of Health and Human Services’ proposal to exclude gender-transition procedures from essential health benefits and encouraged the FDA to incorporate biological sex differences into its regulatory guidance.^[25]

EPPC also urged the Drug Enforcement Administration to preserve state authority over the telemedical prescription of abortion drugs and cross-sex hormones.^[26]

Additional comments addressed the Department of Veterans Affairs’ rule mandating abortion-related benefits, which EPPC opposed, and supported revisions to the Department of Housing and Urban Development’s Affirmatively Furthering Fair Housing regulations, replacing earlier rules criticized for regulatory overreach.^[27][28]